• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    8/15/23 2:01:16 PM ET
    $AAMC
    $AEY
    $AKTX
    $AREN
    Real Estate
    Finance
    Office Equipment/Supplies/Services
    Industrials
    Get the next $AAMC alert in real time by email

    Gainers

    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
    • Delcath Systems, Inc. (NASDAQ:DCTH) shares jumped 85.3% to $5.78 after the company announced FDA approval of HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
    • Tiziana Life Sciences Ltd (NASDAQ:TLSA) surged 40% to $0.8720 after the company announced FDA IND clearance of intranasal foralumab to be studied in Alzheimer's disease.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) shares gained 36.3% to $0.2590 after falling over 7% on Monday.
    • Siyata Mobile Inc. (NASDAQ:SYTA) shares rose 28.3% to $4.2599 following upbeat quarterly sales.
    • Wearable Devices Ltd. (NASDAQ:WLDS) jumped 23% to $1.40 after the company completed first manufacturing batch of the Mudra Band for Apple Watch.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) gained 22.4% to $2.6812 after the company posted strong quarterly sales and announced leadership changes.
    • The Arena Group Holdings, Inc. (NYSE:AREN) shares gained 19.5% to $4.0399 after the company announced it signed a binding letter of intent to combine with Bridge Media Networks.
    • Pharvaris N.V. (NASDAQ:PHVS) gained 19.4% to $22.00 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $10 to $34.
    • LL Flooring Holdings, Inc. (NYSE:LL) shares climbed 18.9% to $4.46 after the company’s board announced exploration of strategic alternatives, including a sale.
    • Paysafe Limited (NYSE:PSFE) gained 18.9% to $14.05. Paysafe reported second-quarter FY23 revenue growth of 6% year-over-year to $402.338 million, beating the consensus of $394.16 million.
    • Taylor Devices, Inc. (NASDAQ:TAYD) rose 18.6% to $22.01 following fourth-quarter results.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 18% to $0.46 after jumping 15% on Monday.
    • Fifth Wall Acquisition Corp. III (NASDAQ:FWAC) climbed 17.7% to $9.00.
    • ENDRA Life Sciences Inc. (NASDAQ:NDRA) gained 16.2% to $1.47 following a narrower-than-expected quarterly loss..
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) jumped 13.6% to $4.0231.
    • ENDRA Life Sciences Inc. (NASDAQ:NDRA) gained 13.4% to $1.4350 after posting a narrower-than-expected loss.
    • Castellum, Inc. (NYSE:CTM) rose 12.4% to $0.5397 after posting better-than-expected quarterly sales.
    • TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) gained 10.8% to $0.4790 after the company reported second-quarter results and priced $5 million public offering of common stock.
    • SomaLogic, Inc. (NASDAQ:SLGC) rose 10.6% to $2.2450 after the company reported better-than-expected second-quarter financial results and issued guidance.
    • NextDecade Corporation (NASDAQ:NEXT) gained 10.3% to $6.10. Stifel upgraded NextDecade from Hold to Buy and raised the price target from $7.5 to $9.
    • 2seventy bio, Inc. (NASDAQ:TSVT) rose 7.4% to $6.47 following second-quarter results.

    Losers

    • F45 Training Holdings Inc. (NYSE:FXLV) shares fell 75.9% to $0.1743 after the company announced it intends to voluntarily delist and deregister its securities.
    • Design Therapeutics, Inc. (NASDAQ:DSGN) fell 68.6% to $2.30 after the company reported initial results from its Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich ataxia. The company said there were injection site reactions.
    • Galecto, Inc. (NASDAQ:GLTO) fell 68% to $0.75 after the company announced topline results from its Phase 2b GALACTIC-1 trial of GB0139 for idiopathic pulmonary fibrosis, which showed the trial did not meet its primary endpoint. The company plans to discontinue development of GB0139.
    • Altisource Asset Management Corporation (NYSE:AAMC) shares fell 67.3% to $10.75 after the company posted a wider second-quarter loss.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) shares fell 64.4% to $0.1395 after posting a loss for the second quarter.
    • MGO Global, Inc. (NASDAQ:MGOL) fell 45.1% to $1.24 after the company reported second quarter financial results.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 42.2% to $0.3688 following second-quarter results.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) fell 39.7% to $0.6086 following weak quarterly sales.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) declined 37.7% to $0.4797.
    • ADDvantage Technologies Group, Inc. (NASDAQ:AEY) fell 35.1% to $0.3755 following a wider quarterly loss.
    • Troika Media Group, Inc. (NASDAQ:TRKA) fell 30% to $1.3744. Troika Media said that the company has terminated employment of CEO, CFO effective Aug. 14.
    • OptimizeRx Corporation (NASDAQ:OPRX) shares fell 29% to $8.87 after posting weak quarterly sales.
    • Sea Limited (NYSE:SE) fell 28% to $41.01 following weaker-than-expected quarterly results.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 25.7% to $0.2098.
    • Nogin, Inc. (NASDAQ:NOGN) declined 23.5% to $0.7495 after the company reported worse-than-expected second-quarter financial results and issued FY23 revenue guidance below estimates.
    • Eastside Distilling, Inc. (NASDAQ:EAST) fell 22.3% to $2.33 following second-quarter results.
    • PhenomeX Inc. (NASDAQ:CELL) fell 19.9% to $0.4875 following weak second-quarter results.
    • Akari Therapeutics, Plc (NASDAQ:AKTX) fell 19.7% to $0.1947 after the company announced ADS ratio change.
    • Proterra Inc. (NASDAQ:PTRA) declined 18.9% to $0.0935.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 15.6% to $0.27.
    • XWELL, Inc. (NASDAQ:XWEL) fell 15.2% to $0.1950 following second-quarter results.
    • Gol Linhas Aéreas Inteligentes S.A. (NYSE:GOL) fell 15% to $3.1525. Citigroup downgraded Gol Intelligent Airlines from Buy to Neutral.
    • 2U, Inc. (NASDAQ:TWOU) fell 13.6% to $3.3750.
    • On Holding AG (NYSE:ONON) fell 13.3% to $29.97 after the company reported mixed quarterly financial results.
    • Rigetti Computing, Inc. (NASDAQ:RGTI) fell 12.7% to $2.33.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) shares declined 12.5% to $5.92. Hanryu shares gained 45% on Tuesday after the company announced it partnered with SALTLUX for the development of an AI-powered conversational virtual assistant on K-culture fandom application.
    • Discover Financial Services (NYSE:DFS) shares fell 9.4% to $93.03 after it disclosed the resignation of Roger C. Hochschild as Chief Executive Officer (CEO) and President.
    • Calliditas Therapeutics AB (NASDAQ:CALT) shares fell 9.2% to $18.50 after the company announced full results from the NefIgArd Phase 3 trial published in The Lancet.
    • Farfetch Limited (NYSE:FTCH) fell 9.2% to $4.76.
    • Getty Images Holdings, Inc. (NYSE:GETY) fell 7.1% to $4.23 after the company reported second-quarter earnings.
    • Array Technologies, Inc. (NASDAQ:ARRY) declined 6.3% to $21.67.

     

    Now Read This: Bitcoin Edges Higher Following Economic Data; Sei Emerges As Top Gainer

    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $AEY
    $AKTX
    $AREN

    CompanyDatePrice TargetRatingAnalyst
    Array Technologies Inc.
    $ARRY
    2/26/2026$9.00Buy → Hold
    Deutsche Bank
    Array Technologies Inc.
    $ARRY
    2/25/2026$19.00Neutral → Outperform
    BNP Paribas Exane
    Galecto Inc.
    $GLTO
    2/17/2026$45.00Buy
    UBS
    Rigetti Computing Inc.
    $RGTI
    2/12/2026Buy → Hold
    TD Cowen
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Rigetti Computing Inc.
    $RGTI
    1/22/2026$35.00Neutral → Buy
    B. Riley Securities
    On Holding AG
    $ONON
    1/20/2026$59.00Neutral → Buy
    Goldman
    More analyst ratings

    $AAMC
    $AEY
    $AKTX
    $AREN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries

    The Dubai Operation strengthens Healthcare Triangle's mission to accelerate TeleHelath, Digital Therapeutics and population-scale care delivery across GCC.PLEASANTON, Calif., Feb. 27, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that its subsidiary QuantumNexis Inc. has launched its Dubai, UAE operations in Meydan Free Zone to deliver clinically validated digital mental health solutions and AI powered Hospital Information System to the GCC markets. "This marks a major strategic expans

    2/27/26 7:18:00 AM ET
    $HCTI
    EDP Services
    Technology

    Paysafe Announces Changes to its Board of Directors

    New appointments bring deep expertise in global payments, digital transformation, marketing, and product innovation Paysafe (NYSE:PSFE), a leading payments platform, today announced the appointment of four new non‑executive directors to its Board, effective February 26, 2026. The new directors bring extensive expertise across global payments, financial services, technology, product innovation, and marketing leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227922419/en/Rupert Keeley Rupert Keeley Rupert Keeley brings significant strategic payments expertise and global regulatory insight to Paysafe. His decades of

    2/27/26 7:00:00 AM ET
    $PSFE
    Real Estate

    Healthcare Triangle Announces Approximately $3.959 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

    PLEASANTON, Calif., Feb. 26, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced today that it has entered into definitive agreements for the purchase and sale of 681,553 shares of common stock (or prefunded warrants in lieu thereof), par value $0.00001 per share, at a purchase price of $5.81 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about February 27, 2026, subject to the satisfaction of customary closing conditions. D. Boral Capital, LLC is acting as sole placement agent fo

    2/26/26 3:26:00 PM ET
    $HCTI
    EDP Services
    Technology

    $AAMC
    $AEY
    $AKTX
    $AREN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hanwha Aerospace Co., Ltd. bought $9,399,378 worth of shares (1,651,971 units at $5.69) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/15/25 7:12:58 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $5,742,414 worth of shares (932,598 units at $6.16) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/10/25 8:15:10 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $3,910,470 worth of shares (636,963 units at $6.14) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/5/25 6:29:01 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AAMC
    $AEY
    $AKTX
    $AREN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Array Tech downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Array Tech from Buy to Hold and set a new price target of $9.00

    2/26/26 7:10:22 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Array Tech upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Array Tech from Neutral to Outperform and set a new price target of $19.00

    2/25/26 7:19:45 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    UBS initiated coverage on Galecto with a new price target

    UBS initiated coverage of Galecto with a rating of Buy and set a new price target of $45.00

    2/17/26 8:59:23 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $AEY
    $AKTX
    $AREN
    SEC Filings

    View All

    Healthcare Triangle Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Healthcare Triangle, Inc. (0001839285) (Filer)

    2/27/26 5:00:18 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form 424B5 filed by Healthcare Triangle Inc.

    424B5 - Healthcare Triangle, Inc. (0001839285) (Filer)

    2/27/26 12:12:02 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form 6-K filed by Paysafe Limited

    6-K - Paysafe Ltd (0001833835) (Filer)

    2/27/26 7:00:02 AM ET
    $PSFE
    Real Estate

    $AAMC
    $AEY
    $AKTX
    $AREN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-7) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 10/01/2024. Application Category: NDA, Application Number: 201848, Application Classification: REMS

    10/2/24 4:43:10 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-3) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 05/22/2024. Application Category: NDA, Application Number: 201848, Application Classification: Labeling

    5/23/24 10:32:08 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-4) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 01/22/2024. Application Category: NDA, Application Number: 201848, Application Classification: REMS

    1/23/24 4:36:46 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    $AAMC
    $AEY
    $AKTX
    $AREN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Yurcisin Jeffrey Michael converted options into 68,291 shares and covered exercise/tax liability with 20,660 shares, increasing direct ownership by 9% to 562,026 units (SEC Form 4)

    4 - Grove Collaborative Holdings, Inc. (0001841761) (Issuer)

    2/19/26 2:31:40 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    CFO Siragusa Thomas converted options into 23,018 shares and covered exercise/tax liability with 9,458 shares, increasing direct ownership by 22% to 74,003 units (SEC Form 4)

    4 - Grove Collaborative Holdings, Inc. (0001841761) (Issuer)

    2/19/26 2:30:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Landesberg Stuart covered exercise/tax liability with 18,466 shares and converted options into 45,059 shares, increasing direct ownership by 2% to 1,524,247 units (SEC Form 4)

    4 - Grove Collaborative Holdings, Inc. (0001841761) (Issuer)

    2/19/26 2:28:23 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AAMC
    $AEY
    $AKTX
    $AREN
    Leadership Updates

    Live Leadership Updates

    View All

    Paysafe Announces Changes to its Board of Directors

    New appointments bring deep expertise in global payments, digital transformation, marketing, and product innovation Paysafe (NYSE:PSFE), a leading payments platform, today announced the appointment of four new non‑executive directors to its Board, effective February 26, 2026. The new directors bring extensive expertise across global payments, financial services, technology, product innovation, and marketing leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227922419/en/Rupert Keeley Rupert Keeley Rupert Keeley brings significant strategic payments expertise and global regulatory insight to Paysafe. His decades of

    2/27/26 7:00:00 AM ET
    $PSFE
    Real Estate

    Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Prafulla Gokhale, Ph.D., Director of the Experimental Therapeutics Core and the Lurie Family Imaging Center at Dana-Farber Cancer Institute, to its Scientific Advisory Board. "Dr. Gokhale's expertise in experimental therapeutics, RNA biology and translational oncology comes at a pivotal time as we advance AKTX-101 toward the clinic," commented Abizer Gaslightwala, President and CEO of Akari Therapeutics. "His proven track record to develop novel t

    2/26/26 9:10:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Olga Anczukow, Ph.D. to its Scientific Advisory Board (SAB). Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics commented, "Dr. Anczukow is a leading authority in RNA splicing and cancer biology, an area of growing importance for the development of next-generation therapeutics. Her scientific rigor, translational mindset, and experience advancing RNA-focused discoveries toward clinical relevance make her an outstandin

    2/23/26 8:50:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $AEY
    $AKTX
    $AREN
    Financials

    Live finance-specific insights

    View All

    Delcath Systems Reports Fourth Quarter and Full Year 2025 Results

    Conference Call Today at 8:30 a.m. Eastern Time Delcath Systems, Inc. (NASDAQ:DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial results and business highlights for the fourth quarter and full year-ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Results Total fourth quarter and full year revenue of $20.7 million and $85.2 million, respectively HEPZATO KIT™ fourth quarter and full year revenue of $19.0 million and $78.8 million, respectively CHEMOSAT® fourth quarter and full year revenue of $1.7 million and $6.4 million, respectively Gro

    2/26/26 8:00:00 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    Getty Images to Release Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. ("Getty Images") (NYSE:GETY) a preeminent global visual content creator and marketplace, announced today that the company intends to release its fourth quarter and full year 2025 results after market close on Monday, March 16, 2026, followed by a conference call at 4:30 p.m. (Eastern Time) that same day to discuss the company's results. The conference call can be accessed live over the phone by dialing 1-800-245-3047, or for international callers, 1-203-518-9765. The conference ID for the call is GETTYQ4. An audio replay will be available for two weeks following the call and can be accessed by dialing 1-844-512-2921,

    2/25/26 4:07:00 PM ET
    $GETY
    Real Estate

    ARRAY Technologies Reports Financial Results for the Fourth Quarter and Full Year 2025

    Achieves 40% Full-Year Revenue Growth, Record Orderbook of $2.2 Billion, Further Expands DuraTrack® Technology to Global Markets and Guides 2026 Revenue to $1.4 Billion to $1.5 Billion 2025 Fourth Quarter Business Highlights Total executed contracts and awarded orders at December 31, 2025 were $2.2 billion(1)Achieved 2x book-to-bill for both total ARRAY and APADuraTrack introduced to global markets to align with customer demand for patented, superior energy performance of wind-stow technology 2025 Fourth Quarter and Full-Year Financial Highlights (in millions, except per share)4Q 2025 FY 2025Revenue$226.0  $1,284.1 Gross margin(2) 8.6%  23.2%Adjusted gross margin(3) 24.5%  27.0%Net loss t

    2/25/26 4:05:00 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $AAMC
    $AEY
    $AKTX
    $AREN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by OptimizeRx Corporation

    SC 13G/A - OptimizeRx Corp (0001448431) (Subject)

    12/6/24 4:26:03 PM ET
    $OPRX
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Rigetti Computing Inc.

    SC 13G - Rigetti Computing, Inc. (0001838359) (Subject)

    12/5/24 10:15:39 AM ET
    $RGTI
    EDP Services
    Technology